Birt-Hogg-Dubé (BHD) syndrome is a rare inherited genodermatosis characterized by hair follicle hamartomas, kidney tumors, and spontaneous pneumothorax. Recombination mapping in BHD families delineated the susceptibility locus to 700 kb on chromosome 17p11.2. Protein-truncating mutations were identified in a novel candidate gene in a panel of BHD families, with a 44% frequency of insertion/deletion mutations within a hypermutable C 8 tract. Tissue expression of the 3.8 kb transcript was widespread, including kidney, lung, and skin. The full-length BHD sequence predicted a novel protein, folliculin, that was highly conserved across species. Discovery of disease-causing mutations in BHD, a novel kidney cancer gene associated with renal oncocytoma or chromophobe renal cancer, will contribute to understanding the role of folliculin in pathways common to skin, lung, and kidney development.
Introduction
clear cell (CCRC, 75%), (2) papillary (PRC, 15%), (3) oncocytoma (5%), and (4) chromophobe (5%) (Kovacs et al., 1997) . CCRC develops in patients with inherited von Hippel-Lindau (VHL) disKidney cancer is a major health problem; worldwide, about 150,000 people develop kidney cancer, with 78,000 deaths from ease, a multisystem neoplastic disorder. Mutations in the VHL tumor suppressor gene are found in the germline of VHL patients metastatic disease each year because available treatments are ineffective (Zbar et al., 2002b) . Mutation screening of inherited and in 50% of sporadic CCRC (Latif et al., 1993) . The VHL gene product, pVHL, is involved in the control of hypoxia-inducible kidney cancer genes in affected families allows presymptomatic diagnosis of family members who are at risk, providing better genes by targeting hypoxia inducible factor-1␣ (HIF-1␣) for ubiquitin-mediated degradation. Mutational inactivation of VHL patient prognosis and disease management.
Kidney cancer may be classified into 4 histologic types: (1) leads to the development of highly vascular tumors through
S I G N I F I C A N C E
Studies of families with inherited cancer have revealed tumor suppressor genes and oncogenes that play a major role in the pathogenesis of human neoplasia. Discovery of protein-truncating mutations in a gene, which occur in patients with BHD and lead to an increased risk for kidney cancer, represents evidence for a novel gene associated with oncocytoma or chromophobe renal histology. Biologic significance of the BHD protein, folliculin, is supported by sequence conservation between folliculin and homologs in mice, Drosophila, and C. elegans, and by mapping studies that suggest that germline mutations in dog and rat BHD homologs lead to inherited renal cancer. Because BHD is a novel gene, further studies of the BHD protein may lead to the elucidation of novel mechanisms of tumorigenesis. 
A:
The BAC tiling path is shown by black horizontal lines with arrowheads indicating directional read of completed sequence and Genbank accession numbers. BAC overlaps were confirmed by in silico and PCR methods. A single gap was spanned by exons of the COPS3 gene. Locations of polymorphic markers, shown in red, and genes, shown in blue, were confirmed in silico and by PCR amplification from BAC clones. Telo, telomere; cent, centromere. B: Critical recombinants identified in Family 243 (D17S2196), Family 210(CA109), and Family 216 (CA138) define the BHD minimal region to 700 kb. Nonrecombining region is in green. C: Location of 2 overlapping, uncharacterized mRNAs from melanoma (Genbank accession numbers BC015725 and BC015687) are shown within the 700 kb BHD candidate region. The BHD gene exon/intron structure with 14 coding exons is given.
upregulation of hypoxia-inducible genes (Kondo and Kaelin, families revealed a diagnosis of Birt-Hogg-Dubé syndrome (BHD) in 3 of 5 families (Toro et al., 1999 (Toro et al., ). 2001 .
Hereditary papillary renal carcinoma (HPRC) occurs less We considered whether BHD skin lesions (fibrofolliculomas) could be used as a marker to identify a novel kidney cancer gene frequently than CCRC and predisposes patients to develop bilateral, multifocal papillary renal tumors (Zbar et al., 1995) . Actiassociated with renal oncocytoma. Birt-Hogg-Dubé syndrome (BHD) was originally described in a Canadian kindred in 1977 vating mutations in the tyrosine kinase domain of the MET protooncogene were found in HPRC Type I , (Birt et al., 1977 . Fibrofolliculomas appear as white or skincolored papules on the face and upper torso. Histologically, 1999), which constitutively phosphorylate and activate the MET protein (Jeffers et al., 1997) . HPRC Type 2 is associated with they are characterized as multiple, anastomosing strands of proliferating epithelial cells extending from a central hair follicle. inactivating mutations in the fumarate hydratase gene, a Krebs cycle enzyme, which cause hereditary leiomyoma/renal cell carOther phenotypic features found to be associated with BHD included renal neoplasia (Roth et al., 1993; Pavlovich, et al., cinoma (HLRCC) and multiple cutaneous leiomyoma (MCL) (TMLC, 2002) .
2002), lung cysts, and/or spontaneous pneumothorax (Toro et al., 1999; Binet et al., 1986) . Patients with fibrofolliculomas have The cancer-causing genes responsible for renal oncocytoma and chromophobe renal carcinoma have not yet been an increased risk for developing renal neoplasms (7-fold) and spontaneous pneumothorax (50-fold) compared with their unafidentified. To identify genes involved in the pathogenesis of renal oncocytoma, 5 families with multiple, bilateral renal oncofected siblings (Zbar et al., 2002a) . In a study of 130 renal tumors found in 30 BHD patients, the spectrum of renal histology cytomas were identified and clinically evaluated (Weirich et al., 1998) . Interestingly, after noting multiple skin papules (fibrofolincluded 34% chromophobe, 5% oncocytoma, 50% chromophobe/oncocytic hybrid, 9% clear cell, and 2% papillary (Pavliculomas) on the face and neck of a pair of identical twins with bilateral renal oncocytomas, reevaluation of the oncocytoma lovich et al., 2002). Celera, NCBI, and Ensembl), and identified known genes, uncharacterized mRNAs, and spliced EST clusters in the 17p11.2 critical region ( Figure 1A ). A PCR-based approach was used to amplify microsatellites and coding exons of genes to confirm their locations on overlapping BACs. These results and fluorescence in situ We pursued the identification of renal oncocytoma and chrohybridization data (V.M., unpublished data) provided additional mophobe renal carcinoma genes by taking advantage of the support for the BAC order. This 1.5 Mb BAC physical map is in phenotypic association of BHD with these histologic types of agreement with the physical map of Lucas et al. (2001), but disrenal cancer, and recruited families on the basis of a diagnosis agrees with the current UCSC Genome Browser (December 2001) of BHD. We performed linkage analysis in 9 BHD families and and Celera and NCBI (April 2002) genome assemblies. localized the BHD disease locus to a 4 cM region of chromosome 17p11.2 between D17S1857 and D17S805 (Schmidt et High-throughput BHD candidate gene mutation analysis al., 2001), which was confirmed in a Swedish BHD pedigree is used to evaluate a total of 39 genes, mRNAs, and ESTs with associated renal neoplasms (Khoo et al., 2001) . In this on 17p11.2 report, we have used recombination mapping to narrow the We identified candidate genes from the critical region based on BHD disease locus and identified disease-associated mutations expressed sequence tag (EST) evidence of expression in skin, in a novel gene which predisposes patients to develop oncocytic lung, and/or kidney. We determined the exon/intron gene structure, and chromophobe renal tumors, collapsed lung/lung cysts, and BHD skin lesions.
Results
designed intronic primers to amplify coding sequences and splice The pedigree shows cosegregation of the C insertion mutation (C 9 ) with disease (blue symbols, affected status). Individual 9 is an asymptomatic mutation carrier who carries the BHD affected haplotype and a history of spontaneous pneumothorax. B: Family 202. a: Sequence analysis of subcloned PCR product from a BHD affected individual shows the delAGinsC mutation (nt 1087-1088) in exon 7. b: The mutation produced a unique DHPLC heteroduplex peak (insert in black symbol) which cosegregated with disease (black symbols, affected status). Unaffected individuals (white symbols, unaffected status) show a wildtype homoduplex DHPLC peak (insert in white symbol). C: Family 230. a: Sequence analysis of exon 12 in BHD affected individuals shows a C→G mutation (nt 1844) which produces an in-frame terminaton at codon 463. b: The pedigree shows cosegregation of the mutation with disease (blue symbols, affected status). junctions, and performed high-throughput mutation analysis on a as candidate genes. We analyzed additional BHD families by genotyping and haplotype analysis and identified a proximal recombinapanel of patient DNA samples, representing 9 BHD families. Prior to the identification of the BHD gene (see below), we sequenced tion in BHD Family 216, in the marker CA138, which localized the BHD gene to a 1.3 Mb region between CA109 and CA138 ( Figure  321 coding amplicons representing 39 known genes, uncharacterized mRNAs, and spliced EST clusters from the 4 cM region of 1B). Subsequently, we identified a proximal recombination in BHD Family 243, at D17S2196, which narrowed the BHD critical region linkage. This effort identified 129 coding SNPs (single nucleotide polymorphisms), 49 intronic SNPs, 7 polymorphic repeats (i.e., further to 700 kb ( Figure 1B ). poly A tracts), and 6 insertions/deletions. Since no mutations were identified among these amplicons, we pursued more detailed reTissue expression of two overlapping mRNAs from the combination mapping.
BHD critical region suggests a single, potential BHD candidate gene Gene mining within the 700 kb critical region using the UCSC Additional critical recombinants narrow the BHD candidate gene region to 700 kb Human Genome Browser (December 2001) identified two overlapping, uncharacterized, full-length transcripts from skin melanoma In parallel with BHD candidate gene sequencing, we developed 13 polymorphic microsatellite markers to look for additional recom-(BC015725 and BC015687). The coding sequences were supported by additional lung, kidney, and melanoma ESTs (Figure binants in the region of linkage. Further genotyping and haplotype analysis of BHD Family 210, described previously (Schmidt et 1C) . Since BC015725 and BC015687 mRNAs (1.9 kb and 1.7 kb, respectively) shared an overlapping coding exon, we considered al., 2001), identified a recombination in the distal marker CA109, eliminating genes that were telomeric of CA109 from consideration the possibility that they represented alternatively spliced variants of a single gene. We performed Northern blot analysis, using hyfied in Family 201 which would truncate the protein 38 missense amino acids downstream. In order to separate the mutant C 9 (or bridization probes designed from each mRNA, to determine if they coded for the same or different transcripts. Hybridization with C 7 ) allele from the wild-type C 8 allele for sequence analysis, each allele was isolated in a somatic cell hybrid (Papadopoulos et al., probes from either mRNA revealed a 3.8 kb transcript in most normal adult tissues, including skin, lung, and kidney ( Figure 4A ), 1995). Sequence analysis of the somatic cell hybrids established from patients from several of these BHD families confirmed the and in fetal lung, kidney, liver, and brain tissue (data not shown). The 3.8 kb mRNA transcript size was roughly equal to the sum presence of the (C) 9 allele on the affected chromosome 17 and the (C) 8 allele on the wild-type chromosome 17. Cosegregation of of BC015725 and BC015687 mRNAs, suggesting that these two transcripts represent splice variants of a single mRNA that is widely these C tract insertion/deletion mutations in BHD-affected haplotype carriers was confirmed by sequencing ( Figure 2A ). expressed. We regarded the novel gene represented by BC015725 and BC015687 mRNAs as an excellent BHD candidate gene based A complex mutation, delAGinsC, which resulted in a frame shift and predicted protein truncation 11 missense amino acids on the source, tissue expression pattern of the two overlapping mRNAs, and their location in the 700 kb BHD critical region.
downstream, was identified in Family 202 in exon 7 at nt 1087-1088. This complex mutation was shown to cosegregate with disease by DHPLC ( Figure 2B ). The unique DHPLC 2-peak chroMutation analysis of the putative BHD gene reveals frameshift mutations which are predicted matographic profile was produced by separation of heteroduplexes, formed between wild-type and mutant allele amplicons, to truncate the protein The exon/intron structure of the BHD candidate gene represented from homoduplexes (Xiao and Oefner, 2001) . A 28 bp duplication of nt 1378-1405 was found in exon 9 of by BC015725 and BC015687 was determined, and intronic primers were designed to amplify coding sequences and splice juncaffected members of BHD Family 228, whose disease phenotype was previously described (Toro et al., 2002) . This resulted in wildtions from a panel of 9 BHD family probands and 3 unaffected family members. Sequence analysis of the 14 coding exons contype and mutant allele size differences that were distinguishable by electrophoresis of patient-derived amplicons on a 4%-20% tained in these two mRNAs revealed frameshift or termination mutations in 8 of 9 BHD families on the panel (Table 1) .
polyacrylamide gel (Figure 3) . The mutation created a termination codon 79 missense amino acids downstream. A cytosine insertion mutation in a mononucleotide (C) 8 tract (nt 1733-1740) in exon 11 was identified in BHD Families 174, A fourth mutation was identified in BHD Family 230, a C to G at nt 1844, which produced an in-frame termination at codon 463 200, 210, and 216, resulting in a frameshift predicted to truncate the protein 26 missense amino acids downstream. A cytosine in exon 12 ( Figure 2C ). Each family's mutation was present in affected members and asymptomatic BHD haplotype carriers deletion mutation in the same mononucleotide (C) 8 tract was identi-within that family, but was absent in noncarriers and at least 160 folliculin is a novel protein. Sequence conservation has been found normal individuals.
in the mouse, D. melanogaster, and C. elegans, underscoring an important biologic function for the BHD gene in a variety of Hypermutable mononucleotide C tract in exon 11 organisms. Additional support for the importance of the BHD gene is mutated in 44% of BHD families tested comes from kidney cancer models in the dog and the rat. Germline We screened an additional 53 probands from small BHD families mutations in BHD orthologs which map to disease-associated, for mutations in the mononucleotide (C) 8 tract in exon 11 of the syntenic locations in the dog and rat may be responsible for natu-BHD gene. We found C insertions or deletions in 22 of the 53 rally occurring inherited renal malignancies in these species probands, suggesting that this cytosine mononucleotide tract is (Jó nasdó ttir et al., 2000; Hino et al., 2001 ). hypermutable and particularly prone to disease-causing mutations Genes have been identified that cause two of the four main (Table 1) . We have identified a total of 18 (C) 9 mutations and 9 histologic types of renal cancer: VHL, responsible for clear cell (C) 7 mutations in 62 BHD patient samples, a (C) 8 tract mutation renal carcinoma; MET, responsible for papillary renal carcinoma frequency of 44%. Insertion/deletion mutations in genes with hoType I; and FH, responsible for papillary renal carcinoma Type 2. monucleotide tracts have been reported in other inherited human This report describes the discovery of the a novel gene with disdisorders (Rodenhiser et al., 1996 (Rodenhiser et al., , 1997 . A slippage-mediated ease-associated mutations that predispose to the development mechanism during DNA replication of single base repeats may of kidney tumors with oncocytoma and chromophobe histologies. result in these frameshift mutations leading to protein truncation How do germline mutations of the BHD gene lead to renal tumors? (Streisinger et al., 1966) . A founder effect/ancestral mutation in
The consistent finding of truncating mutations in the BHD gene this rare disease is an alternative possibility to hypermutability.
suggests that the BHD gene might be a tumor suppressor gene. Loss of heterozygosity studies should address this possibility. Full length BHD sequence predicts a novel protein, Alternatively, renal tumors may develop by a haploinsufficiency folliculin, conserved across species mechanism or as a consequence of hypermethylation of the wildcDNAs from adult kidney and adult and fetal lung (Clontech) were type BHD allele. Another possibility may be that the inactive BHD used to amplify 3.2 kb of the BHD transcript and sequenced to Ͼ4-allele produced by germline mutations results in a dominant-negafold coverage. Separately, a putative full-length clone was obtained tive effect leading to the BHD phenotype. by screening a normal lung cDNA library (Origene Technologies, Clues to the mechanism of renal tumorigenesis in the BHD Inc.) and was also sequenced to Ͼ4-fold coverage. The full-length syndrome may come from consideration of the disease phenotype. BHD sequence of 3674 nucleotides (AF517523) predicted a pro-
The lung cysts and lung collapse (pneumothorax) that are features tein, folliculin (named for the BHD skin lesion, fibrofolliculoma), with of BHD suggest a defect in a structural protein of the lung wall, an open reading frame of 579 amino acids ( Figure 4B ). Programs which may be a component of the cytoskeletal network. The histolincluded in SEQWEB and PROSITE predicted a 64 kDa cytoogy of the stroma-rich skin lesions suggests a defect in epithelialplasmic protein with a glutamic acid-rich, coil-coil domain, one mesenchymal interaction. N-glycosylation site, three myristoylation sites, and several casein Renal tumor development in patients affected with BHD is kinase II and protein kinase C phosphorylation sites. Although unusual. In contrast to other forms of inherited renal cancer in BLAST alignment against the SwissPro and nonredundant NCBI which affected individuals develop multiple, bilateral renal tumors protein databases found no significant homology with any known of a specific histologic type, individuals affected with BHD have a proteins, folliculin was found to be highly conserved across spepredisposition to develop different histologic types of renal cancer, cies. Folliculin is 92% identical to the mouse ortholog (MGC 37841 including oncocytoma, chromophobe, and clear cell. Clear cell gene product, AAH25820), 22%-36% identical (44%-56% posirenal carcinomas are thought to originate from the proximal renal tive) to the Drosophila melanogaster ortholog (CG8616 gene prodtubule, while renal oncocytomas and chromophobe renal carcinouct, AAF50597), and 27%-28% identical (44%-52% positive) to mas are thought to originate from the distal renal tubule. All of the Caenorhabditis elegans ortholog (F22D3.2 gene product, these histologic types may develop within a single kidney of a AAK31497) by BLASTX (Altschul et al., 1997) and MAST (Bailey BHD-affected individual, suggesting that the BHD mutation affects and Gribskov, 1998) (data not shown). The homologies across the progenitor cell for both distal and proximal renal tubules. Perspecies suggest an important biological role for folliculin in a wide haps the mutation alters the composition of the extracellular matrix, range of organisms.
producing a structural or microenvironmental abnormality that affects the cells of both the proximal and distal renal tubules, leading Discussion to uncontrolled cellular proliferation. We anticipate discovery of novel mechanisms of tumorigenesis through study of this unusual Using a classic positional cloning strategy, we have identified a inherited disorder. gene that plays a critical role in the pathogenesis of an uncommon form of kidney cancer through its association with the more comExperimental procedures mon and clinically detectable phenotype of an inherited disorder Patient recruitment and sampling of the hair follicle. All mutations discovered in the germline of Families affected with BHD were recruited and evaluated at the Clinical affected members of BHD families were predicted to truncate the Center, National Institutes of Health, and also on field trips as described protein, suggesting a loss-of-function mechanism for phenotype (Zbar et al., 2002a) . Participants in this study provided written informed development.
consent. The protocol was approved by the NCI-IRB and by the CI-IRB.
Inspection of the predicted amino acid sequence of the BHD protein, folliculin, and BLAST alignment with available protein data-
Development of microsatellites
bases has not disclosed homology to any known gene or gene BLAST of (CA) 16 , (TATG) 8 , and (TGC) 8 against the BAC genomic sequences from the region identified di-, tri-, and tetranucleotide tracts. Primers were family, or identified key functional domains. This suggests that
